According to LakeShore Biopharma's latest financial reports the company has S$46.01 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-03-31 | S$46.03 M | -35.65% |
2023-03-31 | S$71.53 M | 23.83% |
2022-03-31 | S$57.77 M | -27.83% |
2021-03-31 | S$80.04 M |